Minor Histocompatibility Antigen DDX3Y Induces HLA-DQ5-Restricted T Cell Responses with Limited TCR-Vβ Usage Both In Vivo and In Vitro  David Laurin,

Slides:



Advertisements
Similar presentations
Hematopoietic Stem Cell Transplantation in Australia and New Zealand,  
Advertisements

Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation  Patrick.
Strategies for the Identification of T Cell–Recognized Tumor Antigens in Hematological Malignancies for Improved Graft-versus-Tumor Responses after Allogeneic Blood.
High-Risk Acute Lymphoblastic Leukemia Cells with bcr-abl and Ink4a/Arf Mutations Retain Susceptibility to Alloreactive T Cells  Faith M. Young, Andrew.
Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2.
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Relative Survival of Long-Term Hematopoietic Cell Transplant Recipients Approaches General Population Rates  Ian Nivison-Smith, Judy M. Simpson, Anthony.
How to Treat MDS without Stem Cell Transplantation
HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1- Specific CD4+ T Cell Responses Showing Immunogenicity of all HLA-DPB1.
Potential Role of a Mismatched HLA-Specific CTL Clone Developed Pre-Transplant in Graft Rejection following Cord Blood Transplantation  Hiroto Narimatsu,
Promiscuity of the AlloHLA-A2 Restricted T Cell Repertoire Hampers the Generation of Minor Histocompatibility Antigen-specific Cytotoxic T Cells across.
Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,
Allan D. Hess  Biology of Blood and Marrow Transplantation 
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
Human Leukocyte Antigen–DO Regulates Surface Presentation of Human Leukocyte Antigen Class II–Restricted Antigens on B Cell Malignancies  Anita N. Kremer,
Immunotherapy with Donor T Cells Sensitized with Overlapping Pentadecapeptides for Treatment of Persistent Cytomegalovirus Infection or Viremia  Guenther.
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease  Avital.
Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute.
Adoptive Therapy with T Cells/NK Cells
Sabina Kersting, Leo F. Verdonck 
Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation 
Detection of Microchimerism by Minor Histocompatibility Antigen HA-1 Allele-Specific Nested Polymerase Chain Reaction  Brigitte Wieles, Jos Pool, Richard.
Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells 
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report.
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation  Anita D'Souza,
A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model  Justin N. Baker,
French Multicenter 22-Year Experience in Stem Cell Transplantation for Beta- Thalassemia Major: Lessons and Future Directions  Claire Galambrun, Corinne.
Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation  Laurie H. Sehn, Timothy S. Fenske, Ginna G. Laport 
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report.
Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies  Stefan O. Ciurea, Richard.
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
B Cells and Transplantation: An Educational Resource
Paul A. Hoffmeister, Sangeeta R. Hingorani, Barry E. Storer, K
Sarah A. Holstein, Paul G. Richardson, Jacob P. Laubach, Philip L
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−
Prevalence of Intracellular Galectin-1-Expressing Lymphocytes in Umbilical Cord Blood in Comparison with Adult Peripheral Blood  Szonja Kollár, Noémi.
Disparity in Survival Outcome after Hematopoietic Stem Cell Transplantation for Hematologic Malignancies According to Area of Primary Residence  Keshav.
Clinical Application of the Dried Blood Spot Method in the Measurement of Blood Busulfan Concentration  Kana Matsumoto, Naoyuki Uchida, Amane Sakurai,
Regression Models for Hazard Rates Versus Cumulative Incidence Probabilities in Hematopoietic Cell Transplantation Data  Brent R. Logan, Mei-Jie Zhang,
HLA-Mismatched, Noninherited Maternal Antigen–Matched Unrelated Cord Blood Transplantations Have Superior Survival: How HLA Typing the Cord Blood Donor's.
Volume 26, Issue 5, Pages (May 2018)
Pauline Damien, David S. Allan 
Galactomannan Antigen Enzyme-Linked Immunosorbent Assay for Diagnosis of Invasive Aspergillosis after Hematopoietic Stem Cell Transplantation  Patrick.
Gerard Socié, K. Scott Baker, Smita Bhatia 
Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1∗01 
Tbo-Filgrastim versus Filgrastim during Mobilization and Neutrophil Engraftment for Autologous Stem Cell Transplantation  Mohammed M. Elayan, Justin G.
What is quality in a transplant program?
Cord Blood Nucleated Cells Induce Delayed T Cell Alloreactivity
Chimeric Antigen Receptor–Modified T Cells: Clinical Translation in Stem Cell Transplantation and Beyond  Stanley R. Riddell, Michael C. Jensen, Carl.
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match  Jason Dehn, Mukta Arora, Stephen Spellman, Michelle Setterholm,
Blood and Marrow Transplant Handbook
CD8 T-cell ability to exert immunodomination correlates with T-cell receptor: Epitope association rate  Guillaume Roy-Proulx, Chantal Baron, Claude Perreault 
Bernard Maybury, Gordon Cook, Guy Pratt, Kwee Yong, Karthik Ramasamy 
Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2.
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses 
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Molecular Therapy - Oncolytics
Early Recovery of CD4 T Cell Receptor Diversity after “Lymphoablative” Conditioning and Autologous CD34 Cell Transplantation  Jan Storek, Zhao Zhao, Yiping.
Hematopoietic Stem Cell Transplantation in Australia and New Zealand,  
Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?
In Memoriam: E. Donnall Thomas
Volume 115, Issue 4, Pages (October 1998)
Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience  Andy I. Chen, Alex McMillan,
Optimal Donor Selection: Beyond HLA
CD137 Expression Identifies Leukemia Specific CTL after in Vitro Priming of Cord Blood T Cells Previously Expanded By CD3/CD28 Co-Stimulation  Jeyaraj.
HLA restriction of spCD4 T-cell responses.
Presentation transcript:

Minor Histocompatibility Antigen DDX3Y Induces HLA-DQ5-Restricted T Cell Responses with Limited TCR-Vβ Usage Both In Vivo and In Vitro  David Laurin, Eric Spierings, Lars T. van der Veken, Abdelbasset Hamrouni, J.H. Frederik Falkenburg, Gerard Souillet, Corine Vermeulen, Annie Farre, Claire Galambrun, Dominique Rigal, Yves Bertrand, Els Goulmy, Assia Eljaafari  Biology of Blood and Marrow Transplantation  Volume 12, Issue 11, Pages 1114-1124 (November 2006) DOI: 10.1016/j.bbmt.2006.07.012 Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Reactivity of H-Y minor H antigen-specific T cell clones toward HLA-DQB1*0501- and HLA-DQB1*0502- but not HLA-DQB1*0503- or HLA-DQB1*0504-expressing male EBV-B LCLs. Clones E6 (A) and L14 (B) were stimulated with various HLA-DQ5-expressing male EBV-B LCLs. Proliferation was measured by thymidine incorporation, as described in Methods. Biology of Blood and Marrow Transplantation 2006 12, 1114-1124DOI: (10.1016/j.bbmt.2006.07.012) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Proliferation of clones E6 and L14 in response to DBY-encoded epitopes. HLA-DQ5-expressing female EBV-B LCLs transduced with RPS4Y, TMSB4Y, EIF1AY, or DDX3Y genes were used to stimulate clone E6 (A) or clone L14 (B). HLA-identical male EBV-B LCLs were used as positive controls. Proliferation was measured by thymidine incorporation, as described in Methods. Biology of Blood and Marrow Transplantation 2006 12, 1114-1124DOI: (10.1016/j.bbmt.2006.07.012) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Proliferation of clones E6 and L14 in response to particular DBY-encoded peptides. A, C, Overlapping peptides from divergent region of DDX3Y were loaded onto autologous EBV-B LCLs. Mix1 contains 11 peptides, corresponding to amino acids 1-123 of DDX3Y DBY, Mix2 contains 11 peptides from regions 114-431, and Mix3 contains 10 peptides from regions 422-630. B, D, Peptides in Mix2 were also used individually (ppt 171-190 sequence is TGSNCPPHIENFSDIDMGEI). HLA-identical male EBV-B LCLs were used as positive controls. Clone E6 (A, B) and clone L14 (C, D) proliferation was measured by thymidine incorporation, as described in Methods. Biology of Blood and Marrow Transplantation 2006 12, 1114-1124DOI: (10.1016/j.bbmt.2006.07.012) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Proliferation of clones E6 and L14 in response to the previously identified minimal peptide for maximal recognition. The 20-amino acid long peptide TGSNCPPHIENFSDIDMGEI (171-190) and the 12-amino acid short peptide HIENFSDIDMGE were loaded onto autologous female EBV-B LCLs; HLA-identical male EBV-B LCLs were used as positive controls. Proliferation of clones E6 (A) and L14 (B) was measured by thymidine incorporation, as described in Methods. Biology of Blood and Marrow Transplantation 2006 12, 1114-1124DOI: (10.1016/j.bbmt.2006.07.012) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Only the P9 residue of HIENFSDIDMGE is critical for epitope recognition by L14 and E6 clones. Irradiated HLADQB1*0501 female EBV-B LCLs were primed for 1.30 hours with the indicated peptides at the concentration of 10 μg/mL or without a peptide as negative control. Then the L14 and E6 clones were added to wells at a ratio of 1:60 (clone:EBV-B LCL). After 3 days, 3H-thymidine (3HT) was added for 16 hours and proliferation was measured as indicated in Methods. Biology of Blood and Marrow Transplantation 2006 12, 1114-1124DOI: (10.1016/j.bbmt.2006.07.012) Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions